Texas Ebola Patient Gets Experimental Treatment

Thomas Eric Duncan will begin taking the experimental drug brincidofovir as his condition grows worse in his fight with the deadly Ebola virus, CBS News reports. Suggested Reading Flint’s Water Crisis Ends With A Major Development Songs by White Artists You Can Add to Your Black Cookout Playlist NBA’s Mike Beasley’s Alleged Gambling Issues Have…

Thomas Eric Duncan will begin taking the experimental drug brincidofovir as his condition grows worse in his fight with the deadly Ebola virus, CBS News reports.

Video will return here when scrolled back into view
Trump’s Tariffs Might Stick Around. What Should We Buy Now?
Trump’s Tariffs Might Stick Around. What Should We Buy Now?

The man, who became the first person to be diagnosed on U.S. soil with Ebola, had traveled from Liberia to Dallas to visit family when he began exhibiting symptoms.

According to CBS News, brincidofovir is an oral antiviral drug that is in the process of being tested to fight other, more common viruses. However, there is hope that it might target Ebola.

Physicians reportedly requested federal permission to administer the drug, which was made by the North Carolina-based company Chimerix Inc., according to CBS News.ย 

Read more at CBS News.

Straight From The Root

Sign up for our free daily newsletter.